Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parameswaran Hari

Showing results (11-20 of 255) with videos related to

Pageof 26
Sort By:
F1000Research|September 10, 2016
Recent advances in understanding multiple myelomaBinod Dhakal, Saulius Girnius, Parameswaran Hari
Science Bulletin|December 22, 2022
Exercise "CALM" and make CAR-T therapy work betterHeng Mei, Parameswaran Hari, Yu Hu
F1000Research|September 20, 2018
Recent advances in understanding and treating immunoglobulin light chain amyloidosisTalha Badar, Anita D'Souza, Parameswaran Hari
Translational Research : the Journal of Laboratory and Clinical Medicine|October 11, 2018
Novel biomarkers in multiple myelomaAdam Levin, Parameswaran Hari, Binod Dhakal
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2016
New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell TransplantationAnita D'Souza, Jiaxing Huang, Parameswaran Hari
JCO Oncology Practice|May 18, 2021
Immunotherapy in Multiple Myeloma-Time for a Second Major Paradigm ShiftMeera Mohan, Parameswaran Hari, Binod Dhakal
The New England Journal of Medicine|March 4, 2006
Reversible posterior leukoencephalopathy syndrome and bevacizumabCevher Ozcan, Stuart J Wong, Parameswaran Hari
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 27, 2004
Temporal discordance between graft-versus-leukemia and graft-versus-host responses: a strategy for the separation of graft-versus-leukemia/graft-versus-host reactivity?Parameswaran Hari, Brent Logan, William R Drobyski
The New England Journal of Medicine|October 13, 2016
Targeting CD38 in Refractory Extranodal Natural Killer Cell-T-Cell LymphomaParameswaran Hari, Renju V Raj, Horatiu Olteanu
Leukemia|June 2, 2020
Multiple myeloma and COVID-19Binod Dhakal, Anita D'Souza, Saurabh Chhabra, et al.
Pageof 26

Showing results (11-20 of 255) with videos related to

Sort By:
Pageof 26
F1000Research|September 10, 2016
Recent advances in understanding multiple myelomaBinod Dhakal, Saulius Girnius, Parameswaran Hari
Science Bulletin|December 22, 2022
Exercise "CALM" and make CAR-T therapy work betterHeng Mei, Parameswaran Hari, Yu Hu
F1000Research|September 20, 2018
Recent advances in understanding and treating immunoglobulin light chain amyloidosisTalha Badar, Anita D'Souza, Parameswaran Hari
Translational Research : the Journal of Laboratory and Clinical Medicine|October 11, 2018
Novel biomarkers in multiple myelomaAdam Levin, Parameswaran Hari, Binod Dhakal
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 9, 2016
New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell TransplantationAnita D'Souza, Jiaxing Huang, Parameswaran Hari
JCO Oncology Practice|May 18, 2021
Immunotherapy in Multiple Myeloma-Time for a Second Major Paradigm ShiftMeera Mohan, Parameswaran Hari, Binod Dhakal
The New England Journal of Medicine|March 4, 2006
Reversible posterior leukoencephalopathy syndrome and bevacizumabCevher Ozcan, Stuart J Wong, Parameswaran Hari
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 27, 2004
Temporal discordance between graft-versus-leukemia and graft-versus-host responses: a strategy for the separation of graft-versus-leukemia/graft-versus-host reactivity?Parameswaran Hari, Brent Logan, William R Drobyski
The New England Journal of Medicine|October 13, 2016
Targeting CD38 in Refractory Extranodal Natural Killer Cell-T-Cell LymphomaParameswaran Hari, Renju V Raj, Horatiu Olteanu
Leukemia|June 2, 2020
Multiple myeloma and COVID-19Binod Dhakal, Anita D'Souza, Saurabh Chhabra, et al.
Pageof 26